{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:32:50Z","timestamp":1792481570408,"version":"4.5.0"},"reference-count":100,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Cardiac Sarcoidosis (CS) is a deadly consequence of systemic sarcoidosis that inflames all three layers of the heart, especially the myocardium\u2014clinical signs of CS range from asymptomatic disease to abrupt cardiac death. CS generally remains undiagnosed secondary to a lack of definitive diagnostic criteria, a high percentage of false negative results on endomyocardial biopsy, and ill-defining clinical manifestations of the disease. Consequently, there is a lack of evidence-based recommendations for CS, and the present diagnostic and therapeutic management depend on expert opinion. The aetiology, risk factors, clinical symptoms, diagnosis, and therapy of CS will be covered in this review. A particular emphasis will be placed on enhanced cardiovascular imaging and early identification of CS. We review the emerging evidence regarding the use of Electrocardiograms (ECGs), Magnetic Resonance Imaging (MRI), and Positron Emission Tomography (PET) imaging of the heart to identify and quantify the extent of myocardial inflammation, as well as to guide the use of immunotherapy and other treatment regimens, such as ablation therapy, device therapy, and heart transplantation, to improve patient outcomes.<\/jats:p>","DOI":"10.3389\/fcvm.2023.1156474","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T06:17:51Z","timestamp":1684477071000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Cardiac sarcoidosis: a comprehensive review of risk factors, pathogenesis, diagnosis, clinical manifestations, and treatment strategies"],"prefix":"10.3389","volume":"10","author":[{"given":"Hussain Haider","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syeda Alishah","family":"Zehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliza","family":"Shahrukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radeyah","family":"Waseem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tooba","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Sheheryar","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fareeha","family":"Batool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Jaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,19]]},"reference":[{"key":"B1","volume-title":"Illustrations of clinical surgery","author":"\u2018Hutchinson","year":"1875"},{"key":"B2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1136\/pgmj.34.391.245","article-title":"The historical aspects of sarcoidosis","volume":"34","author":"Danbolt","year":"1958","journal-title":"Postgrad Med J"},{"key":"B3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/978-1-4899-2971-6_3","article-title":"The immunology of sarcoidosis","volume-title":"Sarcoidosis","author":"Scadding","year":"1985"},{"key":"B4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/0002-9343(77)90121-8","article-title":"Sarcoidosis of the heart","volume":"63","author":"Roberts","year":"1977","journal-title":"Am J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis","volume":"58","author":"Silverman","year":"1978","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1164\/arrd.1984.130.1.29","article-title":"Sarcoidosis: epidemiology and prognosis. A 15-year European study","volume":"130","author":"Hillerdal","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1001\/archinte.1929.00140050098009","article-title":"Boeck\u2019s sarcoid","volume":"44","author":"Bernstein","year":"1929","journal-title":"Arch Intern Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0002-8703(99)70115-8","article-title":"Histologic diagnostic rate of CS: evaluation of endomyocardial biopsies","volume":"138","author":"Uemura","year":"1999","journal-title":"Am Heart J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.mcna.2018.12.011","article-title":"Sarcoidosis","volume":"103","author":"Llanos","year":"2019","journal-title":"Med Clin N Am"},{"key":"B10","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/oxfordjournals.aje.a009096","article-title":"Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization","volume":"145","author":"Rybicki","year":"1997","journal-title":"Am J Epidemiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1034\/j.1399-3003.1999.14d02.x","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis","volume":"14","author":"Costabel","year":"1999","journal-title":"Eur Respir J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3978\/j.issn.2223-3652.2015.12.13","article-title":"CS-state of the art review","volume":"6","author":"Hulten","year":"2016","journal-title":"Cardiovasc Diagn Ther"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02933","article-title":"Sarcoidosis as an autoimmune disease","volume":"10","author":"Starshinova","year":"2020","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01340","article-title":"Environmental risk factors for sarcoidosis","volume":"11","author":"Judson","year":"2020","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1111\/all.14202","article-title":"Silica-related diseases in the modern world","volume":"75","author":"Hoy","year":"2020","journal-title":"Allergy"},{"key":"B16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/resp.13482","article-title":"Bidirectional association between tuberculosis and sarcoidosis","volume":"24","author":"Wang","year":"2019","journal-title":"Respirology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1701397","DOI":"10.1183\/13993003.01397-2017","article-title":"Prospective study of body mass index and risk of sarcoidosis in US women","volume":"50","author":"Dumas","year":"2017","journal-title":"Eur Respir J"},{"key":"B18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.rmed.2016.10.003","article-title":"Smoking, obesity and risk of sarcoidosis: a population-based nested case-control study","volume":"120","author":"Ungprasert","year":"2016","journal-title":"Respir Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0378-4274(96)03728-9","article-title":"Smoking impairs alveolar macrophage activation after inert dust exposure","volume":"88","author":"W","year":"1996","journal-title":"Toxicol Lett"},{"key":"B20","first-page":"610","article-title":"Sarcoidosis in identical twins","volume":"32","author":"Yoshikawa","year":"1994","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"key":"B21","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1055\/s-2008-1055419","article-title":"Sarkoidose bei eineiigen zwillingen","volume":"120","author":"Kneitz","year":"2008","journal-title":"Dtsch Med Wochenschr"},{"key":"B22","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1001\/jama.1954.73690290007006d","article-title":"Sarcoidosis in identical twins","volume":"155","author":"Rogers","year":"1954","journal-title":"J Am Med Assoc"},{"key":"B23","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00259-007-0650-8","article-title":"Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis","volume":"35","author":"Ohira","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jctube.2017.02.001","article-title":"Histopathologic review of granulomatous inflammation","volume":"7","author":"Shah","year":"2017","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"B25","first-page":"167","article-title":"Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations","volume":"119","author":"Perry","year":"1995","journal-title":"Arch Pathol Lab Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1136\/hrt.2005.080481","article-title":"Cardiac sarcoidosis","volume":"92","author":"Doughan","year":"2006","journal-title":"Heart"},{"key":"B28","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.clindermatol.2007.03.005","article-title":"Gene-environment interactions in sarcoidosis: challenge and opportunity","volume":"25","author":"Culver","year":"2007","journal-title":"Clin Dermatol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"170","DOI":"10.5582\/irdr.2015.01023","article-title":"Sarcoidosis and the heart: a review of the literature","volume":"4","author":"Ipek","year":"2015","journal-title":"Intractable Rare Dis Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","article-title":"Statement on sarcoidosis","volume":"160","year":"1999","journal-title":"Am J Respir Crit Care Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12149-019-01431-z","article-title":"Diagnosis of CS: an era of paradigm shift","volume":"34","author":"Sharma","year":"2020","journal-title":"Ann Nucl Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.5858\/2009-0274-RA.1","article-title":"CS: a pathology-focused review","volume":"134","author":"Lagana","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1378\/chest.07-2784","article-title":"Cardiac involvement in patients with sarcoidosis","volume":"133","author":"Mehta","year":"2008","journal-title":"Chest"},{"key":"B34","doi-asserted-by":"publisher","first-page":"546","DOI":"10.5114\/aoms.2011.24118","article-title":"CS: a comprehensive review","volume":"4","author":"Sekhri","year":"2011","journal-title":"Arch Med Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","article-title":"JCS 2016 Guideline on diagnosis and treatment of cardiac sarcoidosis- digest version","volume":"83","author":"Terasaki","year":"2019","journal-title":"Circ J"},{"key":"B36","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s11886-019-1238-1","article-title":"CS","volume":"21","author":"Mankad","year":"2019","journal-title":"Curr Cardiol Rep"},{"key":"B37","doi-asserted-by":"publisher","first-page":"CMC.S15713","DOI":"10.4137\/CMC.S15713","article-title":"CS: clinical manifestations, imaging characteristics, and therapeutic approach","author":"Houston","year":"2014","journal-title":"Clin Med Insights Cardiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"559","DOI":"10.5114\/aoms.2019.88393","article-title":"A new electrocardiographic parameter associated with sudden cardiac death in pulmonary sarcoidosis","volume":"16","author":"Emet","year":"2020","journal-title":"Arch Med Sci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/clc.21982","article-title":"Cardiac sarcoid: a clinician\u2019s review on how to approach the patient with cardiac sarcoid","volume":"35","author":"Mantini","year":"2012","journal-title":"Clin Cardiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with CS","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"B41","doi-asserted-by":"publisher","first-page":"458","DOI":"10.12659\/PJR.897708","article-title":"Serum ACE level in sarcoidosis patients with typical and atypical HRCT manifestation","volume":"81","author":"Kahkouee","year":"2016","journal-title":"Pol J Radiol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"396","DOI":"10.4132\/jptm.2020.06.10","article-title":"Indirect pathological indicators for CS on endomyocardial biopsy","volume":"54","author":"Cha","year":"2020","journal-title":"J Pathol Transl Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.117.006145","article-title":"Outcome of CS presenting with high-grade atrioventricular block","volume":"11","author":"Nordenswan","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.117.006764","article-title":"Urinary 8-hydroxy-2\u2032-deoxyguanosine as a myocardial oxidative stress marker is associated with ventricular tachycardia in patients with active CS","volume":"10","author":"Ishiguchi","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"B45","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s00380-016-0881-3","article-title":"T wave amplitude in lead aVR as a novel diagnostic marker for CS","volume":"32","author":"Tanaka","year":"2017","journal-title":"Heart Vessels"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.jcmg.2016.11.019","article-title":"Complementary role of CMR to conventional screening in the diagnosis and prognosis of CS","volume":"10","author":"Kouranos","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1111\/echo.13281","article-title":"Improved detection of myocardial damage in sarcoidosis using longitudinal strain in patients with preserved left ventricular ejection fraction","volume":"33","author":"Murtagh","year":"2016","journal-title":"Echocardiography"},{"key":"B48","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.1016\/j.ijcard.2013.07.010","article-title":"Myocardial mechanics for the early detection of CS","volume":"168","author":"Aggeli","year":"2013","journal-title":"Int J Cardiol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/ejhf.205","article-title":"Subclinical left ventricular dysfunction by echocardiographic speckle-tracking strain analysis relates to outcome in sarcoidosis","volume":"17","author":"Joyce","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"B50","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13550-016-0207-6","article-title":"A dual tracer 68Ga-DOTANOC PET\/CT and 18F-FDG PET\/CT pilot study for detection of CS","volume":"6","author":"Gormsen","year":"2016","journal-title":"EJNMMI Res"},{"key":"B51","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/tpj.13577","article-title":"Retraction: \u201cAn \u223c400\u2005kDa membrane-associated complex that contains one molecule of the resistance protein Cf-4\u2019 by Susana Rivas, Tatiana Mucyn, Harrold A. van den Burg, Jacques Vervoort and Jonathan D. G. Jones","volume":"29","year":"2017","journal-title":"Plant J"},{"key":"B52","first-page":"61","article-title":"Biodistribution of the Ga-68 labeled somatostatin analogue DOTA-NOC in patients with neuroendocrine tumors: characterisation of uptake in normal organs and tumor lesions","volume":"54","author":"Prasad","year":"2010","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"B53","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10554-005-9043-x","article-title":"Utility of gallium-67 scintigraphy for evaluation of CS with ventricular tachycardia","volume":"22","author":"Futamatsu","year":"2006","journal-title":"Int J Cardiovasc Imaging"},{"key":"B54","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/bmb\/ldv033","article-title":"Advances in radionuclide imaging of CS","volume":"115","author":"Kouranos","year":"2015","journal-title":"Br Med Bull"},{"key":"B55","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000047316","article-title":"Technetium-99\u2005m sestamibi\/tetrofosmin myocardial perfusion scanning in cardiac and NonCS","volume":"94","author":"Eguchi","year":"2000","journal-title":"Cardiology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1007\/s12350-017-1178-3","article-title":"Gallium-68 DOTANOC scan in a patient with suspected CS","volume":"25","author":"Passah","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s12350-014-9861-0","article-title":"Role of multimodality imaging including thallium-201 myocardial perfusion imaging in the diagnosis and monitoring of treatment response in CS","volume":"21","author":"Surasi","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1148\/radiology.172.1.2500678","article-title":"Occlusive and reperfused myocardial infarcts: differentiation with mn-DPDP\u2013enhanced MR imaging","volume":"172","author":"Saeed","year":"1989","journal-title":"Radiology"},{"key":"B59","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1445-5994.2008.01674.x","article-title":"Cardiac magnetic resonance imaging in the evaluation of CS: an Australian single-centre experience","volume":"39","author":"Manins","year":"2009","journal-title":"Intern Med J"},{"key":"B60","doi-asserted-by":"publisher","first-page":"862","DOI":"10.2214\/AJR.07.3089","article-title":"MRI of CS: basal and subepicardial localization of myocardial lesions and their effect on left ventricular function","volume":"191","author":"Ichinose","year":"2008","journal-title":"Am J Roentgenol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1136\/jim-2016-000144","article-title":"Resolution of abnormal cardiac MRI T2 signal following immune suppression for CS","volume":"64","author":"Crouser","year":"2016","journal-title":"J Invest Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2214\/ajr.185.1.01850110","article-title":"Effectiveness of delayed enhanced MRI for identification of CS: comparison with radionuclide imaging","volume":"185","author":"Tadamura","year":"2005","journal-title":"Am J Roentgenol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12968-015-0168-3","article-title":"2015 update on acute adverse reactions to gadolinium based contrast agents in cardiovascular MR. Large multi-national and multi-ethnical population experience with 37788 patients from the EuroCMR registry","volume":"17","author":"Bruder","year":"2015","journal-title":"J Cardiovasc Magn Reson"},{"key":"B64","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1148\/radiol.210559","article-title":"Neurologic effects of gadolinium retention in the brain after gadolinium-based contrast agent administration","volume":"302","author":"Ayers-Ringler","year":"2022","journal-title":"Radiology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/j.jacc.2005.01.047","article-title":"Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of CS","volume":"45","author":"Smedema","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/S0002-9343(01)00677-5","article-title":"Diagnosis of CS and evaluation of the effects of steroid therapy by gadolinium-DTPA\u2013enhanced magnetic resonance imaging","volume":"110","author":"Shimada","year":"2001","journal-title":"Am J Med"},{"key":"B67","first-page":"1301","article-title":"High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue","volume":"36","author":"Yamada","year":"1995","journal-title":"J Nucl Med"},{"key":"B68","first-page":"1551","article-title":"FDG Uptake and glucose transporter subtype expressions in experimental tumor and inflammation models","volume":"42","author":"Mochizuki","year":"2001","journal-title":"J Nucl Med"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1093\/eurheartj\/ehi180","article-title":"Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis\u2020","volume":"26","author":"Ishimaru","year":"2005","journal-title":"Eur Heart J"},{"key":"B70","first-page":"188","article-title":"Artifactual inhomogeneities in myocardial PET and SPECT scans in normal subjects","volume":"36","author":"Bartlett","year":"1995","journal-title":"J Nucl Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.594200","article-title":"Multimodality imaging of CS before and after steroid therapy","volume":"113","author":"Tadamura","year":"2006","journal-title":"Circulation"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1161\/hc0902.103432","article-title":"Positron emission tomography predicted recovery of complete A-V nodal dysfunction in a patient with CS","volume":"105","author":"Takeda","year":"2002","journal-title":"Circulation"},{"key":"B73","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1097\/RLU.0b013e31827a27df","article-title":"18F-FDG PET\/CT for the assessment of disease extension and activity in patients with sarcoidosis","volume":"38","author":"Ambrosini","year":"2013","journal-title":"Clin Nucl Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1007\/s12350-011-9422-8","article-title":"Utility of high fat and low carbohydrate diet in suppressing myocardial FDG uptake","volume":"18","author":"Harisankar","year":"2011","journal-title":"J Nucl Cardiol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"W151","DOI":"10.2214\/AJR.07.2409","article-title":"Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet","volume":"190","author":"Williams","year":"2008","journal-title":"Am J Roentgenol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"568","DOI":"10.2967\/jnumed.115.166884","article-title":"Additional heparin preadministration improves cardiac glucose metabolism suppression over low-carbohydrate diet alone in 18F-FDG PET imaging","volume":"57","author":"Scholtens","year":"2016","journal-title":"J Nucl Med"},{"key":"B77","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1053\/snuc.2002.127291","article-title":"Positron emission tomography imaging in non-malignant thoracic disorders","volume":"32","author":"Alavi","year":"2002","journal-title":"Semin Nucl Med"},{"key":"B78","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1542-474X.2011.00418.x","article-title":"Effect of corticosteroid therapy on ventricular arrhythmias in patients with CS","volume":"16","author":"Yodogawa","year":"2011","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2022.04.007","article-title":"Update on CS","author":"Tan","year":"2022","journal-title":"Trends Cardiovasc Med"},{"key":"B80","doi-asserted-by":"publisher","first-page":"e155","DOI":"10.1016\/j.crvasa.2017.05.012","article-title":"Management of CS\u2014a practical guide","volume":"60","author":"Kop\u0159iva","year":"2018","journal-title":"Cor Vasa"},{"key":"B81","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1046\/j.1365-2249.1997.d01-979.x","article-title":"Corticosteroids restore the balance between locally produced Th1 and Th2 cytokines and immunoglobulin isotypes to normal in sarcoid lung","volume":"108","author":"Milburn","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.4049\/jimmunol.1202891","article-title":"Reversal of global CD4+ subset dysfunction is associated with spontaneous clinical resolution of pulmonary sarcoidosis","volume":"190","author":"Oswald-Richter","year":"2013","journal-title":"The Journal of Immunology"},{"key":"B83","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ijcard.2014.12.056","article-title":"Isolated CS: clinical characteristics, diagnosis and treatment","volume":"182","author":"Isobe","year":"2015","journal-title":"Int J Cardiol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00015385.2017.1325633","article-title":"CS: a diagnostic and therapeutic challenge","volume":"73","author":"Timmers","year":"2018","journal-title":"Acta Cardiol"},{"key":"B85","first-page":"133","article-title":"Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block","volume":"20","author":"Kato","year":"2003","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"B86","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.amjcard.2021.03.017","article-title":"Effect of corticosteroid therapy in patients with CS on frequency of venous thromboembolism","volume":"149","author":"Kolluri","year":"2021","journal-title":"Am J Cardiol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","article-title":"Methotrexate and its mechanisms of action in inflammatory arthritis","volume":"16","author":"Cronstein","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2169\/internalmedicine.53.0794","article-title":"Treatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesions","volume":"53","author":"Nagai","year":"2014","journal-title":"Intern Med"},{"key":"B89","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/MCP.0b013e3283642a7a","article-title":"Multinational evidence-based world association of sarcoidosis and other granulomatous disorders recommendations for the use of methotrexate in sarcoidosis","volume":"19","author":"Cremers","year":"2013","journal-title":"Curr Opin Pulm Med"},{"key":"B90","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and detection of sarcoidosis. An official American thoracic society clinical practice guideline","volume":"201","author":"Crouser","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"B91","doi-asserted-by":"publisher","first-page":"182","DOI":"10.15420\/aer.2020.09","article-title":"Management of CS in 2020","volume":"9","author":"Gilotra","year":"2020","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"B92","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo","volume":"324","author":"Echt","year":"1991","journal-title":"N Engl J Med"},{"key":"B93","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.semarthrit.2017.03.005","article-title":"Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: a multi-center study of 132 patients","volume":"47","author":"Jamilloux","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.15420\/cfr.2021.16","article-title":"CS: when and how to treat inflammation","volume":"7","author":"Giblin","year":"2021","journal-title":"Card Fail Rev."},{"key":"B95","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/europace\/eus316","article-title":"Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with CS","volume":"15","author":"Kron","year":"2013","journal-title":"EP Europace"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","article-title":"Prognostic determinants of long-term survival in Japanese patients with CS treated with prednisone","volume":"88","author":"Yazaki","year":"2001","journal-title":"Am J Cardiol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.hrthm.2008.10.039","article-title":"Role of radiofrequency catheter ablation of ventricular tachycardia in CS: report from a multi-center registry","volume":"6","author":"Jefic","year":"2009","journal-title":"Heart Rhythm"},{"key":"B98","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"B99","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00392-021-01920-0","article-title":"Short- and long-term outcomes after heart transplantation in CS and giant-cell myocarditis: a systematic review and meta-analysis","volume":"111","author":"Bobbio","year":"2022","journal-title":"Clin Res Cardiol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.healun.2005.02.016","article-title":"Recurrence of CS in a heart transplant recipient","volume":"24","author":"Yager","year":"2005","journal-title":"J Heart Lung Transplant"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1156474\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T06:18:01Z","timestamp":1684477081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1156474\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,19]]},"references-count":100,"alternative-id":["10.3389\/fcvm.2023.1156474"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1156474","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,19]]},"article-number":"1156474"}}